文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外膜氧合治疗COVID-19相关急性呼吸窘迫综合征:叙述性综述

Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review.
PubMed 文献 · J Intensive Care · 2023-02-08
一句话结论VV-ECMO是COVID-19相关ARDS难治性呼吸衰竭的默认选择,合并严重右心功能障碍时可考虑VA-ECMO或Oxy-RVAD。

该叙述性综述总结了COVID-19相关ARDS中ECMO应用的最新证据。对于最大药物治疗难治的严重ARDS,ECMO可减轻呼吸机诱导肺损伤并提供肺休息以待恢复;VV-ECMO是难治性呼吸衰竭的默认选择,合并严重右心室功能障碍时也可考虑VA-ECMO或机械右心室辅助装置联合体外气体交换(Oxy-RVAD)。ECMO也已用于孕妇、重症COVID-19儿科患者等特殊人群,以及作为持续且看似不可逆呼吸衰竭患者成功肺移植的桥接。疫情期间COVID-19相关ARDS的死亡率被多次重新评估。

要点

  • VV-ECMO是COVID-19相关ARDS难治性呼吸衰竭的默认选择。
  • 合并严重右心室功能障碍时,也可考虑VA-ECMO或机械右心室辅助装置联合体外气体交换(Oxy-RVAD)。
  • ECMO用于最大药物治疗难治的严重ARDS,以减轻呼吸机诱导肺损伤并提供肺休息以待恢复。
  • ECMO已用于孕妇和重症COVID-19儿科患者等特殊人群。
  • 持续且看似不可逆的呼吸衰竭患者中,ECMO可作为成功肺移植的桥接。

适用人群与场景

  • 最大药物治疗难治的严重急性呼吸窘迫综合征(ARDS)患者。
  • 住院COVID-19患者中发生ARDS的比例人群。
  • 特殊人群:孕妇、重症COVID-19儿科患者。
  • 持续且看似不可逆呼吸衰竭、作为肺移植桥接的病例。

处置流程与药物剂量

  • VV-ECMO是管理难治性呼吸衰竭的默认选择。
  • 合并严重右心室功能障碍时,也可考虑VA-ECMO或机械右心室辅助装置联合体外气体交换(Oxy-RVAD)。
  • ECMO用于最大药物治疗难治的患者,以减轻呼吸机诱导肺损伤并提供肺休息以待恢复。
  • 持续且看似不可逆呼吸衰竭的病例中,ECMO可作为成功肺移植的桥接。

研究设计与关键结果

  • 叙述性综述总结了COVID-19相关ARDS不同患者人群中ECMO应用的最新证据。
  • 疫情期间COVID-19相关ARDS的死亡率被多次重新评估。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of ventilator-induced lung injury and provide lung rest while awaiting recovery. The mortality of COVID-19-related ARDS was variously reassessed during the pandemic. Veno-venous (VV) ECMO was the default choice to manage refractory respiratory failure; however, with concomitant severe right ventricular dysfunction, venoarterial (VA) ECMO or mechanical right ventricular assist devices with extracorporeal gas exchange (Oxy-RVAD) were also considered. ECMO has also been used to manage special populations such as pregnant women, pediatric patients affected by severe forms of COVID-19, and, in cases with persistent and seemingly irreversible respiratory failure, as a bridge to successful lung transplantation. In this narrative review, we outline and summarize the most recent evidence that has emerged on ECMO use in different patient populations with COVID-19-related ARDS.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Alessandri F, Di Nardo M, Ramanathan K, et al. Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review. J Intensive Care. 2023. PMID: 36755270. doi:10.1186/s40560-023-00654-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。